The latest news about Pfizer

a { color: #880000 !important; background: #ffeeee !important; } Why is in the news at the moment?

Stories involving

Novo Nordisk Faces Competition in Obesity Drugs

Novo Nordisk's semaglutide, marketed as Ozempic and Wegovy, is poised to become the top-selling drug franchise globally. However, competition from Eli Lilly's Zepbound and other emerging treatments could challenge its dominance. Meanwhile, Smoothie King has launched a new menu catering to users of GLP-1 medications, reflecting the growing popularity of these drugs among Americans.

Obesity Drugs: Mixed Results for Patients

Recent reports highlight that up to 20% of patients using popular obesity medications like Wegovy and Mounjaro may not experience significant weight loss. Experts emphasize the variability in individual responses to these treatments, urging realistic expectations among users.

Surge in Walking Pneumonia Cases

Walking pneumonia is currently a significant public health concern, with cases rising sharply among children and adults. Experts warn that while respiratory virus transmission is low, holiday gatherings could lead to increased illness. Vaccination remains crucial as the winter season approaches, particularly for vulnerable populations.

Trump Appoints RFK Jr. as HHS Secretary

President-elect Donald Trump has nominated Robert F. Kennedy Jr. as Secretary of Health and Human Services, raising significant concerns among public health experts due to Kennedy's controversial views on vaccines and public health. His appointment could reshape U.S. health agencies, including the FDA and CDC, as he aims to promote transparency and address chronic diseases.

Kennedy's FDA Nomination Sparks Market Concerns

Robert F. Kennedy Jr.'s nomination as Health Secretary has led to significant stock declines in vaccine and pharmaceutical companies. His history of vaccine skepticism raises concerns about regulatory changes and investment in the biotech sector, particularly affecting companies like Moderna and Pfizer.

Musk Backs Lutnick for Treasury Secretary

Elon Musk has publicly endorsed Howard Lutnick for Treasury Secretary, emphasizing the need for change over the 'business-as-usual' approach of rival Scott Bessent. As President-elect Trump finalizes his cabinet, Lutnick and Bessent are the leading candidates, with Trump also considering Marc Rowan and Kevin Warsh amid ongoing tensions and differing views on tariffs.